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ABSTRACT
For children younger than ﬁve years, caregivers are responsible for the measurement and
administration of antiretroviral medication doses to children. Failure to adhere to the regimen as
prescribed may lead to high viral loads (VLs), immune suppression and ultimately drug
resistance. In the content of this study, adherence refers to adequate dosing of the medication
by a caregiver. Acquired drug resistance to antiretroviral therapy (ART) is prevalent amongst
children in South Africa, and poor adherence to the dosing regimen by caregivers may be
associated with this problem. In this qualitative study, we purposively recruited 33 caregiver–
child dyads from the Hlabisa HIV Treatment and Care Programme database. Children were
divided into three groups based on their VL at the time of recruitment. Children with a VL≥ 400
cps/ml were grouped as unsuppressed (n = 11); children with a VL≤ 400 cps/ml were grouped as
suppressed (n = 12); and children with no VL data were grouped as newly initiated (n = 10).
Caregiver–child dyads were visited at their households twice to document, by means of video
recording, how treatment was administered to the child. Observational notes and video
recordings were entered into ATLAS.ti v 7 and analysed thematically. Results were interpreted
through the lens of Ecological Systems Theory and the information–motivation–behavioural skills
model was used to understand and reﬂect on several of the factors inﬂuencing adherence within
the child’s immediate environment as identiﬁed in this study. Thematic video analysis indicated
context- and medication-related factors inﬂuencing ART adherence. Although the majority of
children in this sample took their medicine successfully, caregivers experienced several
challenges with the preparation and administration of the medications. In the context of
emerging drug resistance, efforts are needed to carefully monitor caregiver knowledge of
treatment administration by healthcare workers during monthly clinic visits.
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Introduction
In the context of limited antiretroviral (ARV) drug options
available for adults and children in South Africa (Davies
et al., 2011), adherence to a ﬁrst-line regimen is key to
ensure optimal and prolonged beneﬁts of treatment
(Bangsberg et al., 2000; Bangsberg et al., 2003). According
to the latest guidelines on ART initiation among infants,
children and adolescents in South Africa, all children
younger than ﬁve years old should be initiated on ART
and are usually initiated on a ﬁrst-line ART regimen
(Department of Health South Africa, 2014). Second-line
regimens, although available, remain costly and often dif-
ﬁcult to access (Davies et al., 2011). Particular concern has
been raised regarding developing resistance to second-line
regimens, especially as monitoring of patient viral loads
(VLs) is unavailable in many resource-limited settings
(Davies et al., 2011; Fox, Ive, Long, Maskew, & Sanne,
2010; Lessells et al., 2014).
For children younger than ﬁve years who rely on par-
ental or non-parental caregivers to administer their
medication to them daily, adherence becomes an even
greater task to manage. In the context of this study,
adherence refers to adequate dosing of the medication
by a caregiver. In addition to having to provide for chil-
dren’s most basic needs, caregivers have to integrate
and manage complicated regimens into their daily
lives (Coetzee, Kagee, & Bland, 2015). For example, in
the absence of ﬁxed-dose combinations available to
children younger than ﬁve years, caregivers of children
in this age group are required to carefully and accu-
rately measure and administer volumes of liquid drug
formulations to children on ART twice a day (World
Health Organisation [WHO], 2013). Moreover, some
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of the medications have special storage requirements
and some are unpalatable and require creative strategies
to mask their taste in order to aid administration
(Department of Health South Africa, 2014). These fac-
tors highlight several characteristics of paediatric ART
that complicates adherence.
To our knowledge, no study has observed and docu-
mented the barriers and facilitators associated with
treatment administration of ART to children younger
than ﬁve years by their caregivers in their homes during
medication times in the morning and evening. The aim
of this study was to document, by means of video
recording, the barriers to and facilitators of adherence
to ART among children younger than ﬁve years in
rural KwaZulu-Natal.
This study was conceptualised, interpreted and under-
stood through the lens of Ecological Systems Theory
(EST) (Bronfenbrenner, 1979). Ecological theories of
health, like EST, consider individual (situated at the
micro level) as well as environmental (contextual) factors
(meso-, exo- and macro levels) when attempting to under-
stand, or when examining, a target behaviour (see Figure
1). In addition to EST, we used concepts associated with
the information–motivation–behavioural skills (IMB)
model to discuss and explain speciﬁc observed behaviours
in this study (Fisher, Fisher, Amico, & Harman, 2006).
Methods
Setting
The research was conducted in Northern KwaZulu-Natal
(South Africa) under the auspices of the Wellcome
Trust-funded Africa Centre for Population Health
(www.africacentre.ac.za).
Participants and procedure
Purposive sampling was used to select and recruit partici-
pants from two primary healthcare clinics in the study
area. VL status at the time of recruitment was used to
differentiate three groups of children invited to take
part in the study. Children on ART for more than a year
and with two consecutive VLs≥ 400 copies per millilitre
(cps/ml) were grouped as unsuppressed (n = 11); children
on ART for more than a year with a VL ≤ 400 cps/ml
were grouped as suppressed (n = 12); and children with
no VL data were grouped as newly initiated (n = 10).
Adherence counsellors at each of the clinics invited
caregivers to meet with the primary investigator (PI)
(BC) and research assistant (RA) in a private room
after their clinic visit to inform them of the study and
to obtain written informed consent for participation.
Caregivers were informed that the PI and an isiZulu-
speaking RA (to act as an interpreter) were going to
visit each of the recruited caregiver–child dyads at their
homes twice (one morning visit and one evening visit)
to document, by means of video recording, how children
received their ARVs. Participants were not excluded if
they did not consent to video recording. All participants
gave written informed consent, and none objected to
video recording. Furthermore, all participants had indi-
cated that household members were aware that the
child was taking medications. Following each home
visit, participants were handed a food parcel to the
value of R150.00 (£6.26) as a token of our appreciation
for their willingness to participate and their time in
this research.
Ethics
The study received ethical approval from Stellenbosch
University (S12/05/135), permission from the local com-
munity advisory board and the hospital management
before entering into the ﬁeld. Multiple visits to partici-
pants’ households were used to minimise reactivity bias
during observations. Further, both the PI and the RA
documented the visits by means of ﬁeld notes and
semi-structured observation schedules, separately. A
debrieﬁng session was held after each visit to compare
and discuss observations.
Data analysis
The sources of data were the video recordings, ﬁeld notes
and data from the semi-structured observation schedulesFigure 1. The four systems of Bronfenbrenner’s EST.
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used during home visits. Demographic data of the chil-
dren (such as age, gender, etc.) as well as their caregivers
(such as age, marital status, level of education, etc.) were
entered and analysed using SPSS v 22. Field notes and
video data were analysed thematically using ATLAS.ti
v 7 (www.atlasti.com).
Results
Child characteristics
The median age of the children at recruitment was 3.5
years (interquartile range (IQR), 2–4.75) for those
with suppressed VLs, 4 years (IQR: 3–5) for those
with unsuppressed VLs and 2 years (IQR: 2–5) for
those newly initiated on ART. Twelve children were
between 0 and 2 years old, 5 children were 3 years
old, 4 were 4 years old, and 12 were aged 5 years. The
majority of children were female (19 out of 33) and
most of them (18 out of 33) had their biological mother
as primary caregiver. Other primary caregivers were
grandmothers (9 out of 33), fathers (1 out of 33) and
aunts (5 out of 33). The average time on ART was 2.3
years, 2.8 years and 0.4 years amongst children with
suppressed VLs, unsuppressed VLs and those newly
initiated, respectively.
Caregiver characteristics
The median age of the caregivers was 35 years (IQR:
27.5–48), 29 years (IQR: 24–40) and 28.5 (IQR: 25.5–
51) for caregivers of children with suppressed VLs,
unsuppressed VLs and newly initiated on ART, respect-
ively. A greater proportion of caregivers to children with
suppressed VLs (7 out of 12) were married and/or living
with a signiﬁcant other in a permanent union compared
to the other two groups (2 out of 11 – unsuppressed, and
2 out of 10 – new enrollers). Furthermore, a greater pro-
portion of caregivers to children with suppressed VLs
had completed high school (5 out of 12), compared to
the other two groups (2 out of 11 – unsuppressed, and
1 out of 10 – new enrollers). Most of the caregivers (27
out of 33) were unemployed and were receiving either
a child support grant or disability grant from the South
African government. More than half of the caregivers
(19 out of 33) were also ART users. Only 24 (73%) had
received the pre-ART HIV education sessions before
the child was enrolled on treatment. Most caregivers
(25 out of 33) indicated that they were not solely respon-
sible for treatment administration or for attending clinic
visits (11 out of 33), but shared this responsibility with
another member of the household, usually an older sib-
ling. Caregivers reported that all members of the
household were aware that the child was on treatment.
However, it was not fully ascertained whether the house-
hold members knew this treatment was for HIV,
especially in the case of other siblings in the household.
Context-related observations
Medication workspace
The median number of adults and children per house-
hold was three. Households had up to six occupants in
a dwelling consisting of one bedroom and one living
area (approximately 30 m2 in total (Hunter & Posel,
2012)). Thus, overcrowded households were common
amongst the participants in this study and inhibited
the ease with which medication was administered to
the child.
Medication storage
Nearly all of the caregivers stored the medications in the
bedroom. Abacavir (ABC) and Lamivudine (3TC) (both
liquid ARV formulations) and tablets (such as Efavirenz
(EFV), Zidovudine and Stavudine (d4 T)) do not require
refrigeration and it was therefore appropriate to store
these medications at room temperature. The directions
for one of the medications, Lopinavir/ritonavir (LPV/r),
state that it should be kept refrigerated (Department of
Health South Africa, 2013). Although most caregivers
(30 out of 33) had access to a refrigerator, not all caregivers
stored LPV/r in the refrigerator. Compared to children
with suppressed VLs, fewer caregivers of children newly
initiated and with unsuppressed VLs kept LPV/r refriger-
ated (Table 1).
Medications stored in the bedroom were either hid-
den (when kept in plastic bags and stored in a cupboard
in the bedroom), or not hidden (when kept visible on a
table in the bedroom). Compared to children with
supressed and unsuppressed VLs, more of the caregivers
of children who were newly initiated (see Table 1) on
ART did not keep LPV/r in the fridge and preferred to
store medications out of sight. Based on this observation,
it is possible that they were hiding the medications from
younger children, other household members or visitors.
Food given before treatment administration
During the ﬁrst visit to the homes, all of the caregivers
reported that they usually gave food to the child before
treatment administration in the mornings and evenings.
However, there were only four morning (three newly
initiated, and one suppressed VL) and two evening visits
(both newly initiated) in which we had seen a child eat-
ing before treatment was administered or had seen vis-
ible signs that food had been prepared and given. We
did not observe any food given during our visits to the
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households of children with unsuppressed VLs. There
was therefore a mismatch between what caregivers had
stated during the initial home visit and what we observed
during the morning and evening home visits.
Medication-related observations
Liquid formulations
Apart from one child with a suppressed VL, all of the
children received liquid ARV formulations as part of
their regimen. For children under three years (<10
kgs), a ﬁrst-line regimen is a combination of ABC, Lami-
vudine (3TC) and LPV/r. All three of these medications
are available as liquid formulations, and dose changes
vary depending on the weight of the child. For children
between three and 10 years old (>10 kg), a combination
of ABC, 3TC and EFV is recommended (Department of
Health South Africa, 2014). Caregivers are required to
measure the millilitres prescribed for each medication
(usually ranging between 1 and 5 ml) and administer it
to the child. Of children newly initiated on ART, 9
received ABC, 10 received 3TC and 8 received LPV/r
as part of their regimen. Of children with suppressed
VLs, 10 received ABC, 9 received 3TC and 10 received
LPV/r as part of their regimen. Of children with unsup-
pressed VLs, 7 received ABC, 7 received 3TC and 9
received LPV/r as part of their regimen.
The majority of caregivers (observed 20 times during
morning administration, and 13 times during evening
administration) used a separate syringe to measure and
administer each dose (Table 2). One way to aid accurate
measurements of liquid formulations using syringes is
through the use of a syringe nozzle. Syringe nozzles are
small plastic attachments that ﬁt into the opening of
medication bottles and are made especially for syringes.
These devices are typically packaged with the medi-
cations ABC and 3TC. The medication LPV/r does not
come with such a device. Syringe nozzles were
Table 1. Context-related observations.
Newly initiated Suppressed VL Unsuppressed VL
Morning visit
(n = 10)
Evening visit
(n = 6) Morning visit (n = 12) Evening visit (n = 8) Morning visit (n = 11) Evening visit (n = 9)
Medication workspace
Lounge 5 4 9 6 2 4
Bedroom 3 2 2 1 7 3
Kitchen 2 0 1 1 2 2
Medication storage
In bedroom (hidden) 5 3 5 3 3 5
In bedroom (not hidden) 2 1 6 5 7 4
In lounge (hidden) 3 2 0 0 1 0
In lounge (not hidden) 0 0 1 0 0
LPV/r refrigerateda 4 out of 8 2 out of 8 9 out of 10 7 out of 10 5 out of 9 4 out of 9
Food givenb 3 2 1 0 0 0
a27 (10 out of 12 suppressed; 9 out of 11 unsuppressed; 8 out of 10 newly initiated) children were receiving LPV/r as part of their regimen.
bFood given before treatment administration.
Table 2. Medication-related observations.
Newly initiated Suppressed VL Unsuppressed VL
Morning visit
(n = 10)
Evening visit
(n = 6)
Morning visit
(n = 12)
Evening visit
(n = 8)
Morning visit
(n = 11)
Evening visit
(n = 9)
Medication measurement tools
Syringe 6 3 7 5 7 5
Syringe + nozzle 4 2 4 3 1 1
Measuring cup 0 1 1 0 3 3
Measurement issues
Bubble in syringe 1 0 2 1 1 1
Dose checkinga
ABC 2 3 2 0 4 3
3TC 2 3 1 1 4 3
LPV/r 3 3 8 6 6 7
Medication administration (directly or indirectly)c
Syringe (directly) 6 3 9 7 4 4
Measuring cup (indirectly) 4 3 2 1 7 5
Missed dosesb 1 1 0 0 0 0
aDose checking: caregiver checks the measurement dose amount in the syringe for accuracy.
bMissed doses: medication is not taken/given on the day.
cMedication administration: directly – medication injected into child’s mouth using syringe. Indirectly – medication transferred into a cup.
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underutilised amongst the caregivers (only used 15 times
across 56 observations) (Table 2). Observation revealed
that syringe nozzles were used more frequently by care-
givers of children newly initiated (observed six times)
and suppressed on ART (observed seven times) com-
pared to unsuppressed children on ART (observed
twice). Fewer instances were observed among those
with unsuppressed VLs as a large proportion was receiv-
ing LPV/r via syringe only.
However, even with a syringe nozzle intact, caregivers
who chose to use them did so erroneously. In at least two
instances where measurements were taken at a horizon-
tal angle, these measurements led to bubble formations
in the syringe. Figure 2 shows a caregiver (biological
mother) taking a measurement of 3TC with a syringe
nozzle intact. The caregiver can be seen holding the bot-
tle horizontally while the measurement is taken. The
angle at which the doses were measured resulted in
bubbles forming within the syringe, suggesting possible
dose inaccuracy. The dose was not checked (for accu-
racy) by the caregiver after the measurement was
made. In four other instances, it was clear from the
video data that a large bubble had formed in the syringe
(Table 2). In neither of these instances was the bubble
removed, indicating possible under-dosing of that
medication.
Tablet formulations
Tablets and capsules were either swallowed whole or dis-
solved in water or mixed with a taste distractor (e.g.
drinking yoghurt). All the children with suppressed
VLs received their tablets/capsules directly and they
were subsequently swallowed whole.
The tablets of four out of ﬁve children in the unsup-
pressed group were dissolved in water before being
administered. Dissolving tablets into solutions was pro-
blematic in cases where the residue of the tablets
remained behind in the container (usually a cup) and
was discarded by the caregiver when she rinsed out the
medication cup. In all four instances where either a tablet
or capsule had been dissolved in water, residue of the
medications remained behind in glass/cup from which
it was administered. Once administered, the caregiver
rinsed the administration tool and discarded the residue
that remained left over, indicating a possible under-dos-
ing of that medication.
Palatability
Most of the children (no problems with palatability in 38
out of 56 observations) ingested their medications with-
out much resistance (Table 3). However, we observed
four instances (one newly initiated, one suppressed,
two unsuppressed) of children spitting medications
out; two instances of vomiting (one newly initiated,
one unsuppressed); seven instances of coughing (two
newly initiated, four suppressed, one unsuppressed)
during medication administration or moaning by the
child; ﬁve instances of child refusal (one instance in
which the child ran away at the time of medication
administration (newly initiated); and four instances
(two newly initiated and two suppressed) where the
child pushed the caregiver’s hand away (Table 3). In all
instances of palatability difﬁculty, the caregiver com-
pleted dose administration. In both instances of vomiting
in particular, the caregivers only administered a partial
dose. As such, children who vomited their medications
did not receive their full dosage.
Discussion
To our knowledge, this is the ﬁrst study to directly
observe factors inﬂuencing adherence to ART amongst
children younger than ﬁve years living in a rural area
in a resource-constrained environment. Ecological
models, like EST, favour behaviour-speciﬁc approaches
to interventions, such as improving adherence to ART
amongst children younger than ﬁve years. Thus, by
using EST in this study, we were able to identify contex-
tual and medication-related factors inﬂuencing adher-
ence to ART among children in a rural area of South
Africa.
Context-related factors
Caregivers in this study showed a preference for keeping
medications hidden. Although caregivers were not
Figure 2. Dose measurement of 3TC taken at an angle. The
image illustrates the caregiver of a suppressed child on ART
taking a measurement of 3TC at a horizontal angle.
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explicitly asked why they chose to store medications in
this way, one might presume that caregivers were hiding
the medications from young children or from visitors.
Keeping medications hidden adds to the large body of lit-
erature on HIV-related stigma (Bogart, Cowgill, & Ken-
nedy, 2008; Brown, Macintyre, & Trujillo, 2003; Katz
et al., 2013; Rintamaki, Davis, Skripkauskas, Bennett, &
Wolf, 2006; Ware, Wyatt, & Tugenberg, 2006). In this
instance, perceived stigma prevented caregivers from
accessing cue-based strategies, such as visibility of the
medications in their homes, for reminder purposes
(Marhefka et al., 2008).
We also observed little to no food administered
prior to treatment administration. However, the lack
of food and the subsequent administration of medi-
cation suggest that caregivers were willing to adminis-
ter treatment without food. Caregivers’ willingness to
adhere to ART in the absence of available resources
has often been associated with what Olds, Kiwanuka,
Ware, Tsai, and Haberer (2015) have referred to as
the “Lazarus effect” (p. 586). In their study, based on
the observable improvements in children’s health due
to ART use, caregivers of children in rural Uganda
were less inclined to miss treatment out of fear that
the child may become ill again (Olds et al., 2015). Fur-
thermore, willingness to provide treatment in the
absence of food also contradicts evidence from care-
givers and healthcare workers. For example, in our pre-
vious work, caregivers to children in the same study
area as well as doctors, nurses and counsellors reported
that lack of food was one of the most important barriers
to adherence to ART(Coetzee et al., 2015). While this
barrier has been shown to be true in other contexts
as well (Haberer & Mellins, 2009; Simoni et al., 2007;
Vreeman, Wiehe, Pearce, & Nyandiko, 2008), our
data suggest that this does not always mean that
doses are missed.
Medication-related factors
Our results demonstrated that caregivers of children on
ART were knowledgeable about some aspects of the
medication, but lacked the necessary skills with which
to perform accurate measurements of the doses. In sev-
eral instances, erroneous medication preparation
appeared to lead to under-dosing. According to the
IMB model (Fisher et al., 2006), information is a necess-
ary condition for behavioural change, but it is not sufﬁ-
cient to bring about that change in itself. Adequate
motivation to adhere to the regimen as well as behav-
ioural skills to administer the medication effectively are
required for behavioural change to occur. While care-
givers used medication tools such as syringes and medi-
cation cups to measure doses of the medications, they
lacked the necessary skills required for performing accu-
rate measurements, such as dose checking (especially
checking that all of the contents of dissolved tablets
and capsules were administered) and removing bubbles
in syringes. These ﬁndings concur with other studies
assessing dosing accuracy among caregivers on ART
(Howard et al., 2014; Yin et al., 2008).
Caregivers to children living in rural areas have low
levels of health literacy (Howard et al., 2014), which
may contribute to misunderstandings of how best to
administer the medication to children. In other research,
we showed that adherence counsellors provided little
information to caregivers during monthly clinic sessions,
which we attributed to the rushed training that adher-
ence counsellors received and the lack of follow-up and
debrieﬁng (Coetzee et al., 2015). However, caregivers to
children with suppressed and unsuppressed VLs tended
to use devices such as syringe nozzles less frequently than
those newly initiated on ART. Thus, carelessness may
also be a consequence of treatment fatigue (Bagenda
et al., 2011).
While most of the children took their medicines suc-
cessfully, several still struggled with the palatability of the
formulations. In the few instances where vomiting was
observed, this may have been attributable to the lack of
food in household. Other studies have shown that lack
of food before ART is often accompanied by noxious
side effects (Biadgilign, Deribew, Amberbir, & Deribe,
2009; Fetzer et al., 2011). Taste-masking and pill-swal-
lowing interventions have contributed suggestions for
Table 3. Child-related observations.
Newly initiated Suppressed VL Unsuppressed VL
Morning visit
(n = 10)
Evening visit
(n = 6)
Morning visit
(n = 12)
Evening visit
(n = 8)
Morning visit
(n = 11)
Evening visit
(n = 9)
Palatability
No palatability issues 5 4 10 3 8 8
Spitting 1 0 1 0 2 0
Vomiting 1 0 0 0 0 1
Cough/moans 2 0 0 4 1 0
Refusal 1 2 1 1 0 0
Taste distracter used (yes) 0 1 2 2 1 1
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strategies with which caregivers may deal with these
issues (Bain-Brickley, Butler, Kennedy, & Rutherford,
2011). However, these interventions have not been
shown to improve adherence to medication in children.
These ﬁndings need to be interpreted against several
limitations inherent to this research. Although necessary
given the methods used, the sample was limited, as only
caregivers whose co-household residents knew about the
child’s medication taking were recruited. Furthermore,
the presence of the PI and RA in participant homes
undoubtedly biased some of the observations. Although
these ﬁndings cannot be generalised, the knowledge is
transferable to similar contexts.
Conclusions
The ﬁndings from this research demonstrate the impor-
tance of understanding context-speciﬁc and age-speciﬁc
factors that inﬂuence adherence to ART among infants
and young children. By stratifying these factors accord-
ing to the micro-, meso-, exo- and macro levels at
which they occur, targeted interventions may be devel-
oped. To aid accuracy during treatment administration,
caregivers’ knowledge of the regimen ought to be moni-
tored regularly by adherence counsellors or relevant
healthcare staff. Furthermore, in order to facilitate accu-
rate transfer of knowledge to caregivers, adherence coun-
sellors need to receive regular follow-up training and
debrieﬁng sessions. Further research is needed to develop
palatable ARV formulations for infants and young chil-
dren on ART.
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